Tech Company Financing Transactions
RootPath Genomics Funding Round
On 8/31/2018, RootPath Genomics raised $7 million in Seed financing from Sequoia Capital, Baidu Venture Capital and Nest.Bio Ventures.
Transaction Overview
Company Name
Announced On
8/31/2018
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors
Sequoia Capital (Lead Investor) (Cyber Cao)
Nest.Bio Ventures (Hingge Hsu)
Volcanics Venture (Suyang Zhang)
Proceeds Purpose
The company will use its proceeds to advance its immuno-oncology programs and obtain key data on accuracy, efficacy and safety in animal models.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
65 Grove St. 203
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Our next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xi Chen
Co-Founder
Cheryl Cui
Co-Founder
Yinqing Li
Co-Founder
Ely Porter
Browse more venture capital transactions:
Prev: 8/31/2018: Openland venture capital transaction
Next: 8/31/2018: Bulb venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs